John K. Scott Jr. - 15 Nov 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director, 10%+ Owner
Signature
/s/ Erika L. Eves for John K. Scott, Jr. by power of attorney
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
+$30
Form type
4
Filing time
02 Dec 2021, 15:13:43 UTC
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $30 +30,000 +0.37% $0.001000* 8,077,162 15 Nov 2021 Direct F1
transaction NAVB Common Stock Award $0 +2,483 +0.03% $0.000000 8,079,645 15 Nov 2021 Direct F2, F4
transaction NAVB Common Stock Award $0 +1,250 +0.02% $0.000000 8,080,895 30 Nov 2021 Direct F3, F4
holding NAVB Common Stock 10,139 15 Nov 2021 By spouse and children F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant.
F2 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.
F3 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F4 Issuance deferred at the request of the Reporting Person.
F5 Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.